Screener
Eli Lilly LLY Reportable Segment — Cost of Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $22,974 | $15,558 | $42,773 | $28,286 |
| Costs, expenses, and other: | ||||
| Cost of sales | 3,268 | 2,448 | 6,845 | 4,672 |
| Research and development | 3,819 | 3,336 | 7,329 | 6,070 |
| Marketing, selling, and administrative | 3,430 | 2,753 | 6,364 | 5,221 |
| Acquired in-process research and development | 2,776 | 154 | 3,360 | 1,726 |
| Asset impairment, restructuring, and other special charges | 703 | — | 982 | 35 |
| Other–net, (income) expense | (269) | 90 | (204) | 329 |
Item 1. Financial Statements
FAQ
- What is Eli Lilly's reportable segment — cost of sales?
- Eli Lilly (LLY) reported reportable segment — cost of sales of $3.27B in Q2 2026.
- How has Eli Lilly's reportable segment — cost of sales changed year-over-year?
- Eli Lilly's reportable segment — cost of sales increased by 33.5% year-over-year, from $2.45B to $3.27B.
- What is the long-term trend for Eli Lilly's reportable segment — cost of sales?
- Over 3 years (2022 to 2025), Eli Lilly's reportable segment — cost of sales has grown at a 18.6% compound annual growth rate (CAGR), from $6.63B to $11.05B.
- What does reportable segment — cost of sales mean?
- Includes the direct costs attributable to the production and distribution of the pharmaceutical products sold by the segment. This encompasses raw materials, manufacturing labor, and overhead costs directly tied to the segment's output. Monitoring this helps evaluate the segment's manufacturing efficiency and gross margin potential.
Ask your AI about Eli Lilly's reportable segment — cost of sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude